Approval · Notice of Compliance 31363 · 2023
ERLEADA: Notice of Compliance 31363
Issued August 2, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31363
- Date
- August 2, 2023
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERLEADA | 02540185 | Marketed |
Medicinal ingredients
- APALUTAMIDE 240 MG per TAB